Bone marrow-derived mesenchymal stem cells reduce immune reaction in a mouse model of allergic rhinitis.

Abstract

Administration of BMSCs effectively reduced allergic symptoms and inflammatory parameters in the mice model of AR. BMSCs treatment is potentially an alternative therapeutic modality in AR.